Biological therapy has significantly improved severe asthma treatment, but there are still many knowledge gaps, especially concerning the guidelines for the treatment of patients with overlapping biomarkers, eg, elevated eosinophils and IgE (1). The gene discussed is IGHE; the disease is asthma.